Scotia Capital’s BioNTech BNTX Stock Holding History

Scotia Capital’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.19M	Hold	45,000	–	–	0.02%	353
2026 Q1	$4M	Buy	+45,000	New	+$4.62M	0.02%	326
2025 Q4	–	Sell	-31,600	Closed	-$3.12M	–	899
2025 Q3	$3.12M	Buy	31,600 +6,519	+26%	+$697K	0.01%	373
2025 Q2	$2.67M	Sell	25,081 -85,000	-77%	-$8.59M	0.01%	380
2025 Q1	$10M	Sell	110,081 -65,143	-37%	-$7.29M	0.05%	181
2024 Q4	$20M	Buy	175,224 +30,143	+21%	+$3.44M	0.11%	113
2024 Q3	$17.2M	Buy	145,081 +64,873	+81%	+$5.96M	0.09%	127
2024 Q2	$6.45M	Buy	80,208 +10,208	+15%	+$933K	0.04%	212
2024 Q1	$6.46M	Buy	70,000 +19,999	+40%	+$1.92M	0.04%	219
2023 Q4	$5.28M	Buy	+50,001	New	+$5.04M	0.03%	230
2020 Q3	–	Sell	-3,998	Closed	-$267K	–	705
2020 Q2	$267K	Buy	+3,998	New	+$200K	﹤0.01%	538

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Scotia Capital's BNTX Position: Q2 2026 in Review

Scotia Capital held its BioNTech (BNTX) position steady in Q2 2026 at 45,000 shares worth $4.19M. The position accounts for 0.02% of the portfolio, ranked #353.

Scotia Capital first reported a position in BNTX in Q2 2020 and has held it in 11 quarters since. The position peaked at $20M in Q4 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Scotia Capital held 45,000 shares of BioNTech worth $4.19M as of Q2 2026.
Scotia Capital left its BioNTech share count unchanged in Q2 2026.
BioNTech made up 0.02% of Scotia Capital's portfolio in Q2 2026, its #353 holding.
Scotia Capital first reported a position in BioNTech in Q2 2020 and has held it in 11 quarters since.
Scotia Capital's BioNTech position peaked at $20M in Q4 2024.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Scotia Capital's 13F filing for Q2 2026, filed 11 Aug 2026.